Get started
Author

Agapito Gonzalez

ORCID: 0009-0005-0384-9856
Observed ORCID: 0009-0005-0384-9856
OpenAlex ID: A5079969736
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2023 · John Mascarenhas, Anna Rita Migliaccio, et al. · Clinical Cancer Research · 36
PDF
Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production
2021 · John Mascarenhas, Heidi E. Kosiorek, et al. · Blood · 16
Supplementary Figure S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S5 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S8 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S6 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S9 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S7 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S2 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S4 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S6 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S4 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S3 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S2 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S1 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Table S3 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S8 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Supplementary Figure S5 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
2024 · John Mascarenhas, Anna Rita Migliaccio, et al.
Works count: 97
Citation count: 52
H-index: 2
I10-index: 2
Year
Topic
Type